Bacterial and Miscellaneous Infections of the Liver


Abbreviations

ADPKD

autosomal-dominant polycystic kidney disease

AIDS

acquired immunodeficiency syndrome

APACHE II

Acute Physiologic Assessment and Chronic Health Evaluation II

APC

antigen-presenting cell

AS

anastomotic stricture

AST

American Society of Transplantation

ASTS

American Society of Transplant Surgeons

BSI

blood stream infection

BTI

biliary tract infection

BUN

blood urea nitrogen

CC

choledocholedochostomy

CD

cluster of differentiation

CDC

Centers for Disease Control and Prevention

CJ

choledochojejunostomy

CMV

cytomegalovirus

CR-KP

carbapenem-resistant Klebsiella pneumoniae

CRP

C-reactive protein

CSD

cat-scratch disease

CT

computed tomography

CTX-M

cefotaximase-Munich

DCD

deceased by cardiac death

DDLT

deceased donor liver transplantation

DNA

deoxyribonucleic acid

EMB

ethambutol

ERC

endoscopic retrograde cholangiography

ESBL

extended-spectrum β-lactamase-producing Enterobacteriaceae

FDG

18-F-fluorodeoxyglucose

FHCS

Fitz-Hugh-Curtis syndrome

HIV

human immunodeficiency virus

HLA-DR

human leukocyte antigen–antigen D related

HTB

hepatobiliary tuberculosis

IAI

intraabdominal infections

ICU

intensive care unit

INH

isoniazid

LD

laparoscopic drainage

LDLT

living-donor liver transplant

LPS

lipopolysaccharide

LT

liver transplant

mag A

mucoviscosity-associated gene A

MBL

mannose-binding lectin

MDR

multidrug resistant

MDR-GNB

multidrug-resistant gram-negative bacteria

MELD

model for end-stage liver disease

MRC

magnetic resonance cholangiography

MRI

magnetic resonance imaging

MRSA

methicillin-resistant Staphylococcus aureus

NAS

nonanastomotic strictures

OS

open surgery

PCD

percutaneous catheter drainage

PCP

Pneumocystis (jiroveci) pneumonia

PET

positron emission tomography

PH

peliosis hepatis

PID

pelvic inflammatory disease

PLA

pyogenic liver abscess

PNA

percutaneous needle aspiration

PTC

percutaneous transhepatic cholangiography

PZA

pyrazinamide

RCT

randomized controlled trials

RIF

rifampin

RPR

rapid plasma reagin

rmp A

regulator of mucoid phenotype A gene

SBP

spontaneous bacterial peritonitis

SIRS

systemic inflammatory response

SM

Streptococcus milleri

SNP

single-nucleotide polymorphism

SOT

solid organ transplant

SSI

surgical site infection

STI

sexually transmitted infection

TB

mycobacterium tuberculosis

TLR2

toll-like receptor 2

TLR4

toll-like receptor 4

TMP-SMX

trimethoprim-sulfamethoxazole

US

ultrasound

UTI

urinary tract infection

VRE

vancomycin-resistant enterococcus

VSE

vancomycin-susceptible enterococcus

Introduction

The liver plays a critical role in preventing bacterial and other infections, especially those that arise from the gastrointestinal tract. The Kupffer cells clear bacteria from the portal vein and with the development of cirrhosis these bacteria and other pathogens can enter the circulation via collaterals. The liver is an important immunologic organ and the development of cirrhosis results in an immunocompromised state, making individuals susceptible to a broader range of infections. This chapter covers the topics of bacterial infections in end-stage liver disease, pyogenic liver abscess (PLA), disseminated bacterial infections of the liver, bacterial infections of the liver in liver transplant recipients, and fungal infections of the liver. Parasitic infections including amebic liver abscess and granulomatous infections of the liver are reviewed elsewhere in this book.

Bacterial Infections in Cirrhosis

Bacterial infections are among the leading causes of decompensation in patients with cirrhosis, and result in significant morbidity and mortality each year. Bacterial infections result in sepsis and death more frequently and with greater severity in cirrhosis, resulting in a fourfold increase in the probability of death. Mostly Enterobacteriaceae and Streptococcus species cause spontaneous infections in cirrhotics. Between 64% and 73% of spontaneous bacterial peritonitis (SBP) cases are associated with gram-negative bacteria including Escherichia coli, Klebsiella pneumoniae , and to a lesser degree Citrobacter freundii, Proteus mirabilis, Enterobacter species, and Pseudomonas aeruginosa. Streptococci, Staphylococci , and Enterococcus species, cause approximately 23% to 40% of the cases and anaerobes including Bacteroides, Clostridia, and Lactobacillus are present in mixed polymicrobial infections. Bacterial components such as lipopolysaccharide (LPS) have been implicated in the intense inflammatory responses leading to organ damage, tissue destruction, and cell necrosis. Additionally, the degree of tissue damage caused by bacterial components is related to the hosts' ability to tolerate the inflammatory response. Bacterial infections trigger a cascade of events resulting in renal failure, hepatic encephalopathy, coagulation failure, variceal bleeding, and adrenal insufficiency. As many as 57% to 70% of infected cirrhotic patients meet systemic inflammatory response (SIRS) criteria, yet many are missed because of bradycardia due to the use of beta-blockers and the lack of leukocytosis associated with hypersplenism. Paradoxically, SIRS occurs in noninfected patients with a hyperdynamic circulatory state. In cirrhosis, immune dysfunction leading to increased bacterial infections is an additional risk factor to SBP. The combination of decreased neutrophil mobilization, phagocytic function, and reduced expression of antigen-presenting human leukocyte antigen–antigen D related (HLA-DR) molecules, production of proinflammatory cytokines, macrophage chemotaxis and activation, and reduced opsonization, and complement levels, leaves patients vulnerable to infections. In addition, the level of immune function is further compromised by the use of immunosuppressive medications, malnutrition, and alcohol consumption. Patients with esophageal variceal bleeding in the setting of cirrhosis experience 2.7-fold and 1.9-fold increases in 6-month and 1-year mortality, respectively, due to bacterial infections, with pneumonia and sepsis of unknown etiology being most common. As an example of immune compromise due to cirrhosis, patients with Clostridium difficile infection have a significantly higher mortality rate compared with cirrhotics without C. difficile . Not surprisingly, in a study of patients with end-stage liver disease, those with bacteremia experienced greater mortality compared with healthier patients.

Bacterial infections resulting in circulatory dysfunction are associated with a more pronounced inflammatory response in cirrhotics, which results in more devastating effects. Cirrhotic patients experience increased intestinal permeability and bacterial translocation leading to SBP and bacteremia. In a study of 156 cirrhotic patients with acellular ascites, detection of bacterial DNA in ascitic fluid and plasma correlated with a worse prognosis when compared with those with no bacterial DNA detection. Bacterial translocation with its underlying mechanism of intestinal bacterial overgrowth, immune alterations, and increased intestinal permeability, specifically acts as a trigger for a hyperinflammatory state and hemodynamic dysfunction. Patients also have greater endothelial dysfunction and higher portal pressure in addition to relative adrenal insufficiency resulting in refractory shock, higher risk of developing infections, and overall greater mortality.

In addition, the continued use of third-generation cephalo­sporins over the last 20 years, increase in invasive procedures, exposure to nosocomial infections, and long-term norfloxacin prophylaxis has led to the development of multidrug resistant (MDR) bacteria including extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL), Pseudomonas aeruginosa, Stenotrophomonas maltophilia, Acinetobacter baumanii, methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-susceptible Enterococcus (VSE), and vancomycin-resistant Enterococcus (VRE), and more recently carbapenemase-producing K. pneumoniae. As a result, current recommended empirical antibiotic regimens may not be appropriate for the treatment of nosocomial infections in areas with a high prevalence of MDR bacteria.

Pyogenic Liver Abscess

Epidemiology

Liver abscesses are generally divided into two categories, those pyogenic in nature and the others due to amebic infections. Pyogenic liver abscess (PLA) has been recognized since the time of Hippocrates and was associated with a high mortality until the advent of antibiotic therapy, improved imaging modalities, percutaneous and minimally invasive procedures, and surgical drainage. Subphrenic abscesses share the same pathogenesis as PLA including intraperitoneal processes, appendicitis, diverticulitis, perforated duodenal ulcers, anastomic leaks, or as a postprocedural complication.

In the United States the incidence of hospitalization for PLA was reported at 3.6 per 100,000 population, with a case-fatality rate of 5.6%, and a 4.1% annual average percent increase from 1994 to 2005. In comparison, population-based studies in Canada observed an annual incidence of PLA of 2.3 per 100,000 population. In Denmark, the incidence rate was reported to have been 11.8 and 9.7 per 1,000,000 for men and women, respectively, from 1977 to 2002. In Taiwan, the annual incidence of pyogenic liver abscesses increased from 11.15 per 100,000 to 17.59 per 100,000 between 1996 and 2004. These occurred in the setting of diabetes, malignancy, and renal disease. PLA is generally present in individuals in their fifth and sixth decades of life without significant racial or ethnic differences. The elderly have a higher mortality along with those with cirrhosis, malignancy, and chronic kidney disease. In contrast to the preantibiotic era where the most common cause of PLA was appendicitis and diverticulitis, today it is most commonly associated with biliary disease or is cryptogenic in nature.

Etiology, Pathogenesis, and Pathophysiology

Although a distinct pathophysiologic process has not been reported with PLA, using a mouse model, Chung et al. were able to elucidate the role of T-lymphocytes in the development of liver abscess caused by Bacteroides fragilis . The researchers described the likely mechanisms behind the formation of liver abscess through activation of Kupffer cells after bacterial exposure resulting in cytokine and chemokine production, which in turn activates T cells and natural killer cells. Encapsulation then occurs by fibrosis through cytokine release and the employment of circulating inflammatory cells. Development of PLA is usually due to bacterial invasion through the portal vein or direct extension from a contiguous neoplasm, suppurative processes or infection involving the biliary tract. Penetrating and nonpenetrating traumas and bacteremia via the hepatic artery have also been well documented in earlier literature ( Figs. 40-1 and 40-2 ). The abscess is located most often in the right lobe (71.5% of cases) due to its size and significant portal blood flow, followed by the left lobe (15%), and caudate lobe (0.8%). Bilobar involvement may occur in 12.6% of cases with abscess size ranging from less than 5 cm (40.3%), 5 cm to 10 cm (50.6%), and greater than 10 cm (9.1%). The majority of patients (67.6%) have a solitary abscess versus 32.4% with multiple abscesses and 9.5% with accompanying gas formation. Studies in the 1970s documented changes in the presentation of PLA including increasing age in patients, greater association with malignancy, and a decrease in amoebic infections in the United States. Additionally, the ingestion of foreign bodies leading to perforation and the development of liver abscesses has been well documented. A systematic review of 59 cases identified the most common foreign bodies including fish bones, toothpicks, chicken bones, and, to a lesser degree, metallic foreign bodies.

Fig. 40-1, Common sources of pyogenic liver abscess (PLA).

Fig. 40-2, Computed tomography (CT) of abdomen showing hepatosplenomegaly with innumerable hepatic microabscesses in a patient with HIV and salmonellosis.

Chronic pancreatitis leading to pylephlebitis, also referred to as portal pyemia or septic portal vein thrombosis , has been implicated as a cause of PLA. The development of PLA has been reported from pylephlebitis. This was most commonly seen in the setting of diverticulitis and appendicitis and to a lesser extent, cholecystitis, cholangitis, and inflammatory bowel disease. Bile duct procedures such as biliary enteric anastomosis, biliary stenting, and wide sphincterotomy performed on patients with biliary cysts and liver metastases have been associated with the development of liver abscesses especially after hepatic radiofrequency ablation or chemoembolization. A study of Pseudomonas aeruginosa –associated liver abscesses indicated that a large proportion of patients with hepatobiliary comorbidity were diagnosed immediately following an intraabdominal surgical or endoscopic procedure, or those with a history of intraabdominal procedures. However, a third of the patients in the study had not undergone any invasive procedure and did not have predisposing risk factors for P. aeruginosa infections. Patients with autosomal dominant polycystic kidney disease (ADPKD) can experience infection of hepatic cysts, which can then become complicated by abscess formation.

Studies have indicated a distinct presentation of PLA when associated with hepatic neoplasms. In a study of 318 patients diagnosed with PLA between 2000 and 2009, 29 hepatopancreatobiliary cases were identified, including cholangiocarcinoma, gallbladder cancer, and pancreatic cancer. Patients tended to have similar mean age and comorbid conditions; however, in comparison with patients without malignancy, patients with malignancy and PLA had more hyperbilirubinemia, hepatomegaly, thicker wall abscess, septal lobulation, gas formation, portal thrombophlebitis, aerobilia, polymicrobial infection, and overall greater mortality. In a retrospective analysis of patients admitted for PLA from 2004 to 2008, 12 out of 211 cases of liver abscess were found to be associated with colorectal neoplasia and as such the authors recommended that in patients without known underlying disease, a screening colonoscopy be performed.

Microbiology

Numerous bacteria have been implicated in PLA and case reports of rare organisms are abundant in the literature. Early studies of bacterial causes were mostly associated with infections due to Escherichia coli and other Enterobacteriaceae, aerobic streptococci, and Staphylococcus aureus . Later studies indicated the contribution of anaerobes, including microaerophilic streptococci, Bacteroides, Fusobacterium, and Actinomyces , to PLA and highlighted the fact that 22% to 52% of the cases reported in the literature were due to mixed infections. Brook and Frazier reported a total of 116 isolates from 48 abscesses and found aerobic bacteria in 25% of the cases, anaerobic bacteria in 17%, mixed aerobic and anaerobic bacteria in 58% of cases, and polymicrobial infection in 79% of cases. The main aerobic and facultative isolates were Escherichia coli, Streptococcus , Klebsiella pneumonia, Staphylococcus aureus, and the majority of anaerobes included Peptostreptococcus , Bacteroides , Fusobacterium , Clostridium , and Prevotella species. In Taiwan during the 1990s Streptococcus species (29.5%) and Escherichia coli (18.1%) constituted most of these infections.

In 1981 the first reported cases of Klebsiella pneumoniae PLA associated with septic endophthalmitis, with distinct phenotypic and genotypic features were emerging in Taiwan. Elderly patients were reported to have had lower incidence of gram-positive bacteria and, in contrast to Western nations, polymicrobial infections with K. pneumoniae and E. coli were more common. The authors speculated that this was due to the lower prevalence of inflammatory bowel disease among Asian populations in comparison with Caucasians. Mortality associated with K. pneumoniae PLA is usually in the setting of septic shock and other complications such as spontaneous abscess rupture. This occurs more commonly among diabetics who tend to have larger size abscesses, associated gas formation, and left hepatic lobe involvement. The increased mortality is also seen in the setting of embolic events leading to meningitis, endophthalmitis, and abscesses involving the central nervous system, lungs, muscles, spleen, skin and soft tissues, spine, and long bones. Rare complications reported in the literature include abscess rupture resulting in pyopericardium, subdiaphragmatic abscess, and bilateral endophthalmitis.

In 1994, the first report of K. pneumoniae liver abscess was reported in the United States. This was followed by reports of other cases in Western Europe also in patients who were not of Asian descent. The distinctive pattern of K. pneumoniae strains associated with liver abscesses represents the invasive and metastatic nature of these infections, which have commonly been described in patients with diabetes mellitus. These infections are associated with serotypes K1/K2, with associated virulence factors, including mucoviscosity-associated gene A ( mag A), regulator of mucoid phenotype A gene ( rmp A), and aerobactin. This hypermucoviscous phenotype allows the bacteria to resist phagocytosis and intracellular killing. Almost all cases of PLA complicated by bacteremia and extrahepatic infections are due to infections with K. pneumoniae serotypes K1 or K2, but not all infections with K1 or K2 serotypes result in PLA with extrahepatic manifestations. Fulfillment of both the clinical and microbiologic definitions of the invasive syndrome portends a poor prognosis and warrants immediate and aggressive treatment. In a large retrospective cohort study of patients with PLA, those with K. pneumoniae had a significantly higher incidence of other infections during a 1-year follow-up period. In comparison with the non– K. pneumoniae cohort, these patients suffered significantly more lung abscesses, empyemas, renal and perinephric abscesses, spinal epidural abscesses, and splenic abscesses. In a study comparing the characteristics of patients with Streptococcus milleri (SM) to patients with K. pneumoniae– associated PLAs, those with SM had a higher incidence of active malignancy, were more distinctly symptomatic (fever, chills, right upper quadrant pain), and had greater duration of symptoms and incidence of hepatomegaly. Those with K. pneumoniae suffered greater complications, including bacteremia, septic shock with organ failure, and metastatic infections. The most common cause of infection for both groups was underlying biliary disease.

MRSA-associated PLAs have been described in patients with human immunodeficiency virus (HIV) and other immunodeficiency states. Staphylococcus aureus is implicated less commonly and has been reported in 7% to 10 % of liver abscesses. A retrospective review from 2004 to 2009 of 117 patients revealed that the most common etiology included biliary disease and recent abdominal surgery in MRSA-associated PLA. Community-acquired MRSA PLA has been reported among young patients without predisposing factors, which are often associated with hematogenous spread from complicated skin and soft tissue infections, injection drug use, or catheter/device-related infections.

In contrast to the common bacterial causes of PLA, Pseudomonas aeruginosa infections are reported infrequently in the literature but have been associated with a mortality rate of 20% when compared with 5.3% among patients with nonpseudomonal PLAs. Other causes of PLA reported in the literature include actinomyces, Nocardia species , Yersinia pseudotuberculosis and Y. enterocolitica, Listeria monocytogenes, Campylobacter jejuni, Legionella pneumophila, Mycobacterium tuberculosis, S. typhi or S. paratyphi, and Bartonella henselae. Microorganisms leading to PLA may be assisted by host factors such as diabetes, cirrhosis, malignancy, and acquired immunosuppression including HIV and inherited diseases such as chronic granulomatous disease, Crohn disease, sickle-cell disease, and hemochromatosis.

Clinical Manifestations, Diagnosis, and Management

The classic triad of fever, jaundice, and right upper quadrant tenderness is only present in a minority of patients with PLA. Other symptoms include malaise, fatigue, anorexia, and weight loss, although this can vary based on bacterial and host factors. A large retrospective review of adults with PLA indicated that patients were more likely to be over the age of 50 and diabetic. These older diabetic patients often present with jaundice, pulmonary findings, multiple abscesses, and lower albumin levels in comparison to the younger patients with amoebic infections. PLA has a more atypical presentation among elderly patients where infection is more commonly present with acute respiratory symptoms, septal lobulation, and pneumobilia. The elderly often require longer courses of antibiotic therapy; have greater local recurrence, and mortality. Studies of prognostic factors in PLA have identified findings such as gas-forming abscesses, MDR isolates, anaerobic bacteria, elevated levels of blood urea nitrogen (BUN), and high APACHE II (Acute Physiologic Assessment and Chronic Health Evaluation II) scores at the time of admission.

The diagnosis of PLA may be challenging due the fact that many patients do not present with specific symptoms. Although elevations in alkaline phosphatase levels may alert clinicians to the presence of PLA, normal levels do not exclude the condition. In addition, blood cultures may be positive in only 50% of cases. Gram stains and cultures need to be collected from drained fluid while insuring timely transport of anaerobic samples under appropriate conditions. Due to its lower cost, lack of radiation exposure, greater availability, and noninvasiveness, many experts recommend ultrasound (US) as the initial imaging test for the diagnosis of PLA. US also has a sensitivity of 70% to 90% in making the diagnosis of PLA. However, the role of ultrasound imaging has been questioned for specific situations. In a review of cases admitted via the emergency department, patients with abscesses located in Segment 8 of the liver presented more often with septic shock and experienced a delay in diagnosis. As such, computed tomography (CT) imaging is recommended if there is a high index of suspicion for PLA even in the setting of a negative ultrasound. In addition, contrast-enhanced CT scanning has a sensitivity of 95% and it can assist with interventional drainage procedures. CT images may also provide clues to the etiology and type of organism involved. A study comparing CT image findings in K. pneumoniae –associated liver abscesses to liver abscesses associated with other bacterial pathogens indicated that the presence of a thin abscess wall, necrotic debris, metastatic infection, and the absence of biliary disease could predict K. pneumoniae– associated abscesses with a specificity of 98.6% when at least three of the four criteria were present. Triphasic enhanced multislice CT has also shown greater sensitivity in comparison with sonography. The CT imaging may be visualized in two phases including a presuppurative and suppurative phase where images become delineated and indicate the presence of a capsule. Magnetic resonance imaging (MRI) is an additional imaging tool that can assist with the detection of biliary obstruction as the underlying cause of PLA ( Figs. 40-3 and 40-4 ). Other diagnostic tools reported in the literature include 18-F-fluorodeoxyglucose (FDG) positron emission tomography (PET). PET has been studied in the diagnosis of infected hepatic cysts in patients with ADPKD and has been found to be useful. This is because conventional imaging may not be able to distinguish hemorrhage from infection.

Fig. 40-3, Magnetic resonance imaging (MRI) of abdomen showing left hepatic lobe intrahepatic abscess in a patient with emphysematous cholecystitis.

Fig. 40-4, Magnetic resonance imaging (MRI) of the abdomen showing multiple hepatic abscesses in the right hepatic lobe in a patient with Streptococcus intermedius bacteremia.

Once the microbiologic diagnosis has been made, general recommendations for the treatment of PLA include 2 to 3 weeks of intravenous antibiotic therapy followed by conversion to oral therapy for a 4 to 6 week course, although shorter durations have been recommended in the literature. Documentation of clearance of infection is recommended and may be confirmed by close clinical and imaging follow-up. In a study of 107 patients with PLAs of less than 3 cm, a success rate of 100% was achieved when patients were treated with antibiotics alone. Additional studies have reported similar success rates but may have been subjected to selection bias. Several experts have recommended that antibiotic therapy alone should be reserved for those with small abscesses that cannot be appropriately drained or in those who the expected rate of complication is high, until better patient selection guidelines become available. The topic of MDR organisms will be addressed in the transplant section of this chapter. However, in 2006, the first patient without comorbid conditions or previous hospitalization was diagnosed with CTX-M-15 ESBL-producing K. pneumonia– associated liver abscess, raising the possibility of future increases in community-acquired liver abscess.

Whereas antibiotic therapy is the mainstay in the treatment of PLA, drainage of abscesses greater than or equal to 5 cm result in faster and more successful resolution. Drainage can occur via nonsurgical methods, such as percutaneous needle aspiration (PNA) or percutaneous catheter drainage (PCD). However, a surgical approach, including open surgery (OS) and laparoscopic drainage (LD), may be required in the setting of a ruptured abscess, associated biliary disease, intraabdominal disease, or uncontrolled sepsis. A meta-analysis of five randomized controlled trials (RCTs) from 1998 through 2013, covering 306 patients, indicated that PCD was superior to PNA with regard to clinical improvement and time required to obtain a 50% reduction in cavity size. The rates of complications were reported to have been similar and the advantage in PCD was apparent in abscesses with large cavities that required frequent drainage. Studies investigating the role of laparoscopic surgery (LS) versus OS in the treatment of PLA due to biliary disease have indicated that LS may be efficacious in select patients and has similar outcome to OS. In this report, no significant differences were found with regard to operation time, intraoperative blood loss and transfusion, postoperative complication rate, abscess recurrence, or overall mortality between these two modalities, whereas hospital stay was shorter with LS. Finally, complete surgical resection may be indicated in the setting of rupture, multiloculation, and associated biliary or intraabdominal disease. Recent studies have evaluated the use of inflammatory markers because there are few prognostic tools available to assess the resolution of infection after completion of drainage and antimicrobial therapy. One study identified C-reactive protein (CRP) as an independent factor in the determination of successful antibiotic therapy for postpercutaneous drainage of PLA.

Peliosis Hepatis

Wagner published the first case of peliosis hepatis (PH) in 1861, which he described as a vasculoproliferative disorder of the liver. Schoenlank first introduced the term peliosis hepatis in the literature, mostly in association with tuberculosis. Later, Zak described the unique appearance of the liver with multiple cystic blood-filled cavities. The pathogenesis of PH is not known. Trigger events, such as vascular alterations with parenchymal damage, have been proposed as a mechanism. Its association with Mycobacterium tuberculosis and Bartonella henselae in the setting of acquired immunodeficiency syndrome (AIDS) is well-documented. Additionally, there have been case reports of PH associated with Hansen disease and S. aureus tricuspid valve endocarditis, as well as noninfectious etiologies. In recent literature, PH is defined as the vascular proliferation of sinusoidal hepatic capillaries resulting in blood-filled cavities, which may be found in the spleen, lymph nodes, lung, pleura, stomach, ilium, kidneys, adrenal gland, and bone marrow.

Disseminated Bacterial Infections With Involvement of the Liver

Several disseminated bacterial infections are associated with involvement of the liver in both healthy and immunosuppressed individuals. Cat-scratch disease (CSD) associated with Bartonella henselae infection resulted in 36 such cases with hepatosplenic abscesses in a group of immunocompetent adults. Liver biopsies revealed necrotizing granulomatous hepatitis, and nonspecific chronic hepatitis. The majority of patients were clinically cured and most received less than 2 weeks of oral azithromycin. Vibrio vulnificus infections have been well documented in patients with advanced liver disease. Infections with V. vulnificus are often fatal in patients with liver disease due to the dysregulation of systemic iron metabolism. In a study of mice infected with V. vulnificus , bacterial growth was hastened through the utilization of iron in reducing the phagocytic activity of neutrophils. An autopsy report of five patients indicated a correlation with the consumption of raw seafood a day before the onset of illness. Three of the patients had known cirrhosis and two had alcoholic-associated liver disease. Autopsies of the five patients revealed portal hypertension and gastrointestinal mucosal changes with edema, hemorrhagic necrosis, and lymphocyte infiltration. One patient with HIV presented with phlegmonous colitis, which the authors believe to be the first case of concurrent phlegmonous enterocolitis and V. vulnificus infection. Biopsies of skin lesions of the lower extremities revealed nonspecific acute inflammation of the dermis with vasculitic changes and the presence of gram-negative bacilli in the dermis. Treatment usually consists of a combination of a tetracycline with a third-generation cephalosporin.

Syphilis is a sexually transmitted infection (STI) caused by Treponema pallidum. Syphilis results in dissemination of spirochetes during the secondary phase of infection, which infect the liver. Feher et al. reported 17 cases of syphilitic hepatitis with clinical, biochemical, immunological, and pathologic descriptions. The majority of cases displayed evidence of hepatitis with focal necrotic inflammation in the lobules of the liver with proliferative pattern in central veins, arterioles, and portal veins. Identification of spirochetes is not a consistent histologic finding. This process is different from the presentation of gummas in the liver, which are associated with tertiary syphilis. In a study of syphilitic hepatitis in patients with HIV disease, high rapid plasma reagin (RPR) titers correlated with higher cluster of differentiation (CD) 4 + T lymphocyte counts, which were attributed to the robust inflammatory response resulting in liver damage. The authors noted significant elevation of alkaline phosphatase levels, often out of proportion to transaminase levels, and minimal elevation of bilirubin levels. In another study of patients with early syphilis, 39% had liver enzyme abnormalities and 2.7% of them were diagnosed with syphilitic hepatitis. Penicillin is considered first-line therapy in the treatment of all stages of syphilis.

Coxiella burnetii is an obligate intracellular gram-negative bacterium. It is the zoonotic agent of Q fever, which can be transmitted through the inhalation of aerosols from contaminated urine, feces, milk, or birth products. Infection can result in jaundice, nausea and vomiting, and right upper-quadrant abdominal pain. Rare cases of hepatic and splenic abscesses have been reported in the literature. Additionally, it is associated with granulomatous hepatitis. Brucellosis is a zoonosis caused by microorganisms of the genus Brucella , an intracellular parasite of the reticuloendothelial system. It is gram-negative, immobile, unencapsulated, and an obligate aerobic coccobacillus. The four species causing human infections include Brucella abortus, Brucella melitensis, Brucella suis, and Brucella canis. Contact with the source animal results in infection through the skin or mucous membranes, or ingestion of contaminated unpasteurized dairy products. Brucellosis commonly affects the liver and is associated with hepatomegaly with mild to moderate elevation of liver enzymes in 2% to 3% of patients. Brucelloma is an abscess caused by the bacteria affecting 1.7% of patients and is often associated with a chronic stage of this disease, although reported in both acute or subacute stages of brucellosis. The abscess most commonly forms in the liver but may affect the spleen or liver and spleen. In a large series of patients, histopathologic evaluation revealed a range of findings including nonspecific inflammatory cellular infiltrates, nonspecific hepatitis, hepatic granulomas, clusters of mononuclear cells, lymphocytes, plasma cells, multinucleated giant cells, and, in two patients, fibrosis with central necrosis. Acute presentation of PLA with brucellosis has been reported, although the chronic form of the disease is more common. Chronic, hepatosplenic, suppurative brucellosis was associated with the presence of calcium densities in abscesses. Treatment usually consists of doxycycline for acute infections. Leptospirosis is a zoonotic infection caused by bacterial spirochetes of the genus Leptospira . Humans are incidental hosts and become infected through exposure to water or soil contaminated with the urine of animals or indirect exposure to the bacteria in soil or water. The disease features a wide spectrum of presentations from self-limited or asymptomatic infection to severe life-threatening infection with multiorgan involvement. Weil disease is a distinctive form of disease that results in renal and hepatic dysfunction. The pathogenesis has not been fully elucidated but immune mediation, toxin production, and direct tissue damage have been proposed by several authors. Unlike viral hepatitis, conjugated serum bilirubin levels can increase out of proportion to the serum transaminases and patients may experience a prolonged period with jaundice. However, death due to liver failure is unusual in the absence of renal failure. Early pathologic descriptions of the liver included subcapsular hemorrhage, vascular injury, and destruction of the architecture of the liver followed by cell injury resulting in necrosis in some cases. On autopsy, hepatocyte degeneration, hypertrophied Kupffer cells, cholestasis, erythrophagocytosis, and infiltration of mononuclear cells have been described. Treatment for mild infections includes doxycycline, azithromycin, or amoxicillin.

In 1920, Carlos Stajano first described Fitz-Hugh-Curtis syndrome (FHCS) with its association of adhesions occurring between the liver capsule and anterior abdominal wall in women with prior salpingitis. Its pathogenesis may be related to hematogenous, direct, or lymphatic infection of the liver capsule due to an immune-mediated process to Chlamydia trachomatis and Neisseria gonorrhoeae . The disease results in inflammation of the perihepatic capsule without hepatic parenchymal involvement. It occurs more commonly in women with pelvic inflammatory disease (PID). Disseminated gonococcal infection caused by N. gonorrhea affects 1% to 3% of patients with gonorrhea and has been associated with bacteremia and PLA. Treatment guidelines for these infections are updated on a regular basis by the Centers for Disease Control and Prevention (CDC).

Listeria monocytogenes is a motile gram-positive bacillus transmitted by fecal-oral route and has been associated with sporadic disease and food-borne outbreaks in immunosuppressed, pregnant, elderly, diabetic, and very young patients. Liver involvement is rare and uncommon presentations have included SBP, hepatitis, and, PLA. In large reviews of L. monocytogenes SBP cases in cirrhotic and noncirrhotic patients, those with cirrhosis consistently presented with fever and abdominal pain. The original theories on macrophages functioning as the principal effector cells in listeriosis have recently been challenged. In a new experimental model, a fraction of bacteria escape the antimicrobial activity of neutrophils by intracellular multiplication in hepatocytes. It was further found that Kupffer cells were not responsible for the majority of phagocytosis and that bacteria were cleared by immigrating neutrophils. Braun et al. reported 15 cases and described three distinct patterns of liver infection in L. monocytogenes. This included solitary liver abscess, multiple liver abscesses, and hepatitis. Solitary liver abscesses were reported in diabetics and had a more favorable course than multiple liver abscesses. Hepatitis is the other presentation of this infection, which is accompanied by fever and significant elevation in transaminases, and is often also accompanied by bacteremia and meningitis. Ampicillin is the antibiotic of choice for the treatment of Listeria infections.

Mycobacterium tuberculosis (TB), the causative agent of tuberculosis, has been associated with infections involving every organ. Hepatobiliary tuberculosis (HTB) is uncommon and isolated hepatic tuberculosis is even more rare. A review of 14 patients over a 10-year period included five cases of isolated hepatic and biliary involvement and nine cases with multiorgan involvement representing an annual incidence ranging from 0.0% to 1.05% of all TB infections. Most of the cases were initially thought to have been malignancy resulting in a delay in diagnosis. Only 29% of the patients in this study had findings consistent with pulmonary TB with an overall mortality of 14% due to delay in presentation and diagnosis. Mixed pyogenic infections with tuberculosis have been reported in the literature, although isolated hepatic abscess due to TB is rare. A combination of isoniazid (INH), rifampin (RIF), ethambutol (EMB), and pyrazinamide (PZA) is the most common regimen used in the treatment of tuberculosis.

Miscellaneous Bacterial Infections

Other infections involving the liver include nontuberculosis mycobacteria, clostridia, actinomyces, meliodosis, shigellosis, legionellosis, ehrlichiosis, borreliosis, and staphylococcal and streptococcal toxic shock syndromes.

Conclusions

Bacterial infections in patients with end-stage liver disease contribute to significant morbidity and mortality. Continued efforts are needed to elucidate the underlying role of the immune system in these infections and eliminate factors that increase risk of infection. PLA and disseminated bacterial infections of the liver continue to be present due to the aging of the population and changing environmental and host factors. The increasing frequency of MDR organisms will make the management of these patients increasingly difficult. Preventative measures, rapid diagnostic tools, and new therapeutic modalities are needed to address these challenges.

Bacterial Infections in Liver Transplant Recipients

Infections in liver transplant (LT) recipients are a major cause of morbidity and mortality. Bacterial infections represent approximately 70% of all infections whereas viral and fungal infections represent 20% and 8%, respectively. The incidence of bacterial infections in the first year after LT ranged from 14.1% to 67.9%, depending on the series. Almost half of the bacterial infections occur in the first 60 days after transplant and may be nosocomial or caused by the patient's normal flora, however, donor-derived infections can occur. Bacterial infections among LT recipients can be broadly divided into intraabdominal infections (IAIs), which include superficial and deep surgical site infections (SSIs), biliary tract infections (BTIs), and organ/space infections, blood stream infections (BSIs), urinary tract infections (UTIs), pneumonia, and others. For the purpose of this chapter we will be discussing IAI.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here